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ABSTRACT | Diottix® was calibrated at 25 Hz to achieve 
the frequency indicated in literature as being effective to 
mobilize the airways secretions. However, the amplitude 
and frequency of the waves generated by the equipment 
in different regions of the chest still need to be investigated. 
The objective of this study was to analyze the frequency 
and amplitude of waves generated by Diottix® in chests of 
healthy subjects. Diottix® was used in the anterior and pos-
terior regions of the chest. The mechanical waves were cap-
tured using stethoscopes connected to electret microphones, 
which were connected to a digital oscilloscope. Frequency 
and amplitude data were recorded by the stethoscope, posi-
tioned in six points in the anterior region and six in the pos-
terior region of the chest, following the positions commonly 
used in pulmonary auscultation. Signals were recorded and 
transferred to a computer with software for their analysis. 
The frequency of waves did not present a significant change 
(from 24.9 to 26.4 Hz). The wave amplitude in the anterior 
versus the posterior region in each area of the lung, the 
upper, middle and lower, had differences. Diottix® produces 
frequencies in the chest according to the calibrated; thus, 
it can be a complementary resource to bronchial hygiene 
maneuvers. The amplitudes of waves seem to be affected 
by other structures like bone parts and heart.
Keywords | Chest Wall Oscillation; Respiratory Therapy; 
Vibration.
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RESUMO | O Diottix® foi calibrado a 25 Hz para atingir a fre-
quência indicada na literatura como eficaz a fim de mobili-
zar secreções de vias aéreas. A amplitude e a frequência das 
ondas geradas pelo equipamento nas diferentes regiões do 
tórax ainda precisam ser investigadas. O objetivo de estudo 
foi analisar a frequência e a amplitude das ondas geradas 
pelo Diottix® no tórax de indivíduos saudáveis. A aplicação 
do Diottix® foi realizada nas regiões anterior e posterior do 
tórax. As ondas mecânicas foram captadas utilizando este-
toscópios conectados a microfones de eletreto, os quais esta-
vam ligados a um osciloscópio digital. Os dados de frequência 
e amplitude foram captados pelo estetoscópio, posicionado 
em seis pontos na região anterior e seis na posterior do tórax, 
seguindo as posições comumente utilizadas na ausculta pul-
monar. Os sinais foram registrados e transferidos para um 
computador por meio de um software para análise deles. 
A frequência das ondas não apresentou variação significa-
tiva (24,9 a 26,4 Hz). A amplitude de onda na região anterior 
versus posterior em cada segmento do pulmão, terço supe-
rior, médio e inferior, apresentou diferença. O Diottix® produz 
frequências no tórax de acordo com o calibrado; desta forma, 
pode ser um recurso complementar às manobras de higiene 
brônquica. As amplitudes de ondas parecem ser afetadas por 
outras estruturas, que incluem as partes ósseas e o coração.
Descritores | Oscilação da Parede Torácica; Terapia 
Respiratória; Vibração.
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INTRODUCTION
One of the basic objectives of Respiratory Physical 
Therapy is to facilitate the mucociliary clearance by bron-
chial hygiene maneuvers aiming at maintaining airway 
permeability, preventing the accumulation of secretions 
and facilitating gas exchange1. The constant exposure of 
respiratory mucosa to different types of harmful agents, 
like micro-organisms and air pollutants, can increase the 
production of mucus in the respiratory tract, activating 
the mechanism of mucociliary depuration2. The mucus 
binds to products of cellular degradation and inhaled sub-
stances, and is transported toward the cephalic direction, 
by the ciliary movement of the respiratory epithelium, 
with frequency ranging between 8 and 15 Hz3.
In some respiratory conditions, like chronic bronchi-
tis, bronchiectasis and cystic fibrosis, there is the hyper-
production of mucus, and mucociliary depuration can be 
reduced, which favors the accumulation of secretions and 
contributes with the onset of infections. In this context, 
the development and the use of methods favor muco-
ciliary transport3.
King et al. found a frequency that reduces the viscosity 
of the mucus oscillating between 3 and 16 Hz4. In 1990, 
the same authors concluded that the high-frequency oscil-
lation in the thoracic wall of dogs doubled the tracheal 
clearance in 13 Hz; however, the one in the airway did 
not increase5. Tomkiewicz et al. observed that viscosity is 
reduced after 30 minutes, with an oscillation of 22 Hz6. 
Recently, Mueller et al. reported that the ideal frequency 
to mobilize secretions is around 13 Hz7.
Respiratory Physical Therapy disposes of resources 
that try to mobilize secretions in the airways and increase 
expectoration, thus contributing to improve ventilation, 
oxygenation and, therefore, pulmonary function. Among 
the used procedures are postural drainage techniques, 
controlled breathing, vibrocompression, tracheobronchial 
aspiration, assisted cough, high-frequency percussion and 
oral oscillation, which can be used alone or combined8-11. 
The efficacy of these Respiratory Physical Therapy maneu-
vers is still discussed in literature11-15.
Chatburn11 described some equipment that generates 
high frequency in the thorax, and each of these frequen-
cies was very diverging. The intrapulmonary percussive 
ventilation device operates between 1.7 and 5 Hz; the 
Percussionator (Breas IMP2) works between 1 and 6 Hz; 
the Percussive Neb, between 11 and 30 Hz, and The Vest, 
between 2 and 25 Hz11.
The modalities of manual therapy and auxiliary devices 
for bronchial hygiene present some limitations in terms of 
clinical practice, like, for instance, the presence of osteo-
porosis, which makes the performance of manual thoracic 
percussions impossible. On the other hand, the reduced 
level of consciousness of the patients can limit the use 
of high-frequency oral oscillation devices16.
A device that tries to complement the bronchial 
hygiene resources was proposed, called oscillatory tho-
racic thixotropic device (Diottix® - patent for approval 
with registration number (Utility Model) UM 91016975). 
Diottix® was calibrated at 25 Hz17, however, it is not 
known which frequency this device generates in human 
thorax and what the behavior of mechanical waves in the 
different regions of this organ is.  
In this context, the oscilloscope, which is used to 
assess the frequency in Hz as well as the generated wave 
amplitudes, can be used to analyze these properties of 
the Diottix® in a healthy human thorax, and therefore 
detect the differences between its regions. These results 
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can be used for comparison with other evaluations in 
pathological processes, like the increasing secretion in 
airways, caused by several chronic pulmonary diseases. 
Therefore, this study aimed at analyzing the frequency 
and the amplitude of the waves generated by Diottix® 
in the thorax of healthy humans.
METHODOLOGY
This is a prospective and cross-sectional study. Male and 
healthy individuals, aged more than 18 years old, with-
out previous report of chronic pulmonary diseases, par-
ticipated in the study. Participants did not present any 
changes in the chest wall and had not been submitted 
to surgical procedures in the chest wall. All of the par-
ticipants signed the informed consent form. The project 
was approved by the Research Ethics Committee, pro-
tocol 0068/11.
Individuals presenting respiratory diseases, smokers 
or those who refused to participate in the study were 
excluded.
To characterize the sample, body mass and height were 
measured, and body mass index was calculated (BMI) by 
dividing the weight for the square of the height.
Participants were submitted to the pulmonary func-
tion test by spirometry, which was conducted according 
to the criteria by the American Thoracic Society (ATS, in 
1999) and the Guidelines for Pulmonary Function Tests, 
in 2002, in a portable spirometer18,19 (IQ TeQ Spirometer, 
version 4.891, South Africa). After a five-minute rest, 
three forced, reproductive and acceptable vital capacity 
tests were performed. The analyzed variables were forced 
vital capacity (FVC), forced expiratory volume in the first 
second (FEV1) and the ratio VEF1/CVF.
Preparation to capture waves
Mechanical waves were obtained by using three stetho-
scopes connected to electret microphones, which were 
attached to a digital oscilloscope (Model DSO 2090 40 
mHz, two USB channels, QinkDao, China). The data 
obtained by the oscilloscope were transmitted to a com-
puter and registered by the software DSO-2090 USB, 
version 7.0.0.0. With the oscilloscope, the frequency was 
obtained in Hertz (Hz), and the amplitude, in millivolts 
(Mv), in two independent channels. Therefore, to cap-
ture waves in the upper, middle and lower thorax, it was 
necessary to use two oscilloscopes. Figure 1 shows one 
with both channels, and Figure 2 presents the experi-
mental design.
Six points were determined in the anterior region (three 
in each hemithorax) and six in the posterior part of the 
thorax (three in each hemithorax), according to the posi-
tions that were usually used in pulmonary auscultation20.
In the anterior region, the first point was located 10 cm 
away from the nipple, in apical direction. The second one 
was 2 cm medially away from the nipple, and the third 
one, 10 cm below the nipple, approximately 10 cm to 
the side. The procedure was repeated in the contralateral 
hemithorax. In the posterior region, six points were also 
determined, three in each hemithorax. The first one was 
located 5 cm away from the spinal process of C7, in the 
Figure 1. DSO 2090 with two channels
Figure 2. Illustrative image of the experimental design. (A) Application of 
Diottix®; (B) stethoscopes placed in the anterior region of the right hemi-
thorax; (C) connected to the electret microphone; (D) connected to the 
oscilloscope and (E) interfaced with the software to analyze the amplitude 
and frequency of signals
A
E
B
C
D
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lateral direction; the second one was 1 cm below the cen-
ter of the medial border of the scapula toward the medial 
direction, and the third one was 2 cm below the inferior 
angle of the scapula in the caudal direction21.
To fixate the electret microphone, one ear tip was 
removed from each stethoscope, which was installed 
inside the metallic arch that connects the conduction tube 
of the sound to the diaphragm. The other metallic arch 
was occluded to address the sound to the microphone. 
Data were collected in a silent place, therefore look-
ing to eliminate the effects of external noise and enable 
the qualified capture of sounds. 
Application of Diottix®
With the stereotypes attached to the anterior region of 
the thorax, Diottix® was applied in the same region, and 
this application was called anterior auscultation with 
anterior application (AAAA). With the stethoscope 
still in the anterior region of the thorax, the device 
was used in the posterior area, which was called ante-
rior auscultation with posterior application (AAPA).
When the stethoscopes were attached to the posterior 
region of the thorax and the Diottix® was applied in the 
posterior region, it was called posterior auscultation with 
posterior application (PAPA), and when stethoscopes 
were in the posterior region and Diottix® was applied in 
the anterior region, it was called posterior auscultation 
with anterior application (PAAA).
The application of Diottix® was performed by the 
approximation of sinuous prolongations, by a tweez-
ing movement and the posterior rough removal from 
the fingers17.
Statistical analysis
Measures of frequency and amplitude of mechanical waves 
generated by Diottix® were compared between the points 
captured in the right and left hemithorax, and anterior 
and posterior of the thorax, by using a paired sample 
t-test if distribution was normal, and the Wilcoxon test 
if it was not normal. For the relationship between  the 
apex, the middle third and the base, the one-way analy-
sis of variance (Anova) was used, with the Holm-Sidak 
Method as a discriminatory post-test. When data did 
not present the pre-requirements of normal distribution 
and the same variance, the Kruskal-Wallis test was used. 
Statistical analysis was conducted with the software Sigma 
Stat for Windows (version 3.5), with a significance level 
(p<0.05) and a 95% confidence interval.
RESULTS
Fifteen male subjects were assessed. Data regarding age, 
weight, height, BMI, spirometry of the studied sample 
are presented in Table 1.
Table 1. Characterization of the sample and pulmonar function
Characteristic Mean±SD
Age (years) 23.8±4.9
Weight (kg) 72.1±13.4
Height (cm) 172±9.2
BMI (kg/cm2) 24.3±1.6
FVC (%) 95.2±16.9
FEV
1 
(%) 92.4±18.4
FEV
 
/FVC(%) 87.2±0.7
SD: standard deviation; BMI: body mass index; FVC: forced vital capacity; FEV
1
: forced expiratory 
volume in the first second
Table 2. Wave frequency in sites for the application of Diottix® and pulmonary regions
Local 
auscultation
Anterior application Posterior application
Anterior Posterior Anterior Posterior
R L R L R L R L
Superior 1/3 25.2±0.23 25.2±0.15 26.0±1.65 25.2±0.52 25.2±0.62 25.2±0.42 25.2±0.22 25.1±0.18
Medial 1/3 25.2±0.18 25.4±0.37 25.0±0.57 25.7±0.40 25.1±1.09 25.8±1.18 24.9±0.64 25.3±0.20
Inferior 1/3 25.1±0.25 25.3±0.29 25.1±0.40 26.4±1.43 25.1±0.54 25.3±0.45 25.2±0.20 25.0±0.38
Data in mean±standard deviation. There were no differences between applications and regions of auscultation
Table 3. Amplitude of wave in places of Diottix® application and in pulmonary regions
Local 
auscultation
Anterior application Posterior application
Anterior Posterior Anterior Posterior
R L R L R L R L
Superior 1/3 48.0±17.3 66.3±15.8 20.5±9.7 17.6±14.5 19.7±4.0 20.5±8.3 75.3±9.5# 45.3±16.9&
Medial 1/3 49.7±16.7 45.7±18.7* 16.6±8.5 17.8±13.1 17.9±5.3 17.0±4.3 73.6±9.9# 49.2±19.3
Inferior 1/3 58.2±17.1 41.2±16.5* 25.6±4.8 19.7±16.3 18.0±5.4 20.1±3.8 61.2±17.1 59.3±17.3&
Data in mean±standard deviation; *p<0.05 (versus 1/3 upper left); #p<0.05 (versus anterior auscultation with right anterior application); &p<0.05 (versus anterior auscultation with left anterior application)
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The wave frequency did not have significant variation 
(24.9 to 26,4 Hz), regardless of the application and aus-
cultation point which are presented in Table 2.
The amplitude of the wave, comparing the right and 
left hemothorax, in each thoracic segment, did not pres-
ent any differences in all forms of application (Table 3).
The comparison of wave amplitude in AAAA versus 
AAPA in each lung segment, right upper third versus 
left, right middle third versus left and right lower third 
versus left, showed significant difference (Table 3).
The amplitude of the wave presented differences in 
AAAA in the left thorax, between the upper and middle 
thirds, and the upper thirds with the inferior left thorax, 
presenting more amplitude in the upper third (Table 3).
DISCUSSION
The main findings in this study are that the frequency 
of Diottix® remained unaltered in the different regions of 
the thorax in comparison to the superior of the left tho-
rax, and in the posterior of the right thorax by relating 
to the anterior region of the same hemithorax when the 
application is posterior and the amplitude is lower in the 
let posterior region in comparison to the anterior region; 
however, it was higher in the inferior region. 
The sound wave assessed in this study is periodical, 
that is, it happens in intervals with the same period. This 
wave system is defined as a harmonic oscillator, once it 
always presents a constant period. In a harmonic oscil-
lator, the equation that describes mass dislocation, or the 
behavior of its velocity with time, is always expressed in 
a sinusoidal function, which provides the following vari-
ables: amplitude, meaning the higher dislocation of mol-
ecules from the middle in relation to the mean point of 
vibration, and frequency, which is the number of cycles 
per unit of time22.
Amplitude is related to the length of vibration, which 
is higher when auscultation is close to the place Diottix® 
was applied (AAAA and PAPA). Therefore, when aus-
cultation is away from the place of application (AAPA 
and PAAA), the wave amplitude is lower, that is, the 
waves generated by the diapason create higher disloca-
tion of the molecules close to the point of application 
and lose intensity while getting more distant from this 
point. It also relates to the density of organic tissues, in 
case of pulmonary parenchyma, and amplitude and peak 
of amplitude are higher22. On the other hand, mediastinal 
organs, such as heart and large vessels, can be responsible 
for the lower values found in the left hemithorax during 
posterior auscultation with posterior application, even 
when Diottix® was used close to the auscultation site.
The amplitude and the frequency of the wave gener-
ated by the Flutter® device VRP1 were assessed by the 
photoacoustic technique using electret microphones and 
showed frequency variation of 1 to 35 Hz20. The ampli-
tude of wave generated by the Flutter® VRP1 was uni-
form in the right hemithorax, so that, in the left side, it 
was larger in the base when compared to the apical and 
medial regions. This fact was explained by the authors 
due to the attenuation of the propagation of sound waves 
generated by the Flutter® VRP1 device in the heart20. 
In this study, the amplitude in the base of the left hemi-
thorax was higher when Diottix® was applied in the pos-
terior region with posterior auscultation, however, this 
difference was not significant.
Flutter® is a device that matches positive expiratory 
pressure (PEP) and high-frequency oscillations, thus 
generating waves by the pressure variation. They reach 
the basal regions, which present higher quantities of pul-
monary tissue and that, consequently, would promote 
higher pressure variation. Diottix®, on the other hand, 
is applied directly on the thoracic region; therefore, it 
does not depend on the pressure oscillation in the air-
ways, but only on the tissues that feel this vibration. So, 
the higher the amount of tissue, the stronger the reduc-
tion of amplitude of the wave.  
Silveira compared the use of Flutter® VRP1 with 
conventional physical therapy among people with cys-
tic fibrosis, and reported that the device can generate 
frequencies of approximately 15 Hz16. The frequency 
manual respiratory physical therapy can reach during 
the maneuvers is controversial in literature, as well as 
its efficacy8. It is possible to observe that, the one found 
in literature about oral oscillation devices is diverging; 
therefore, Diottix® has a differential, according to which 
the frequency ranges little, between 24.9 and 26.4 Hz. 
This instrument was capable of reaching the proposed 
frequency, with the advantage that the frequency varia-
tion is minor, unlike Flutter® VRP1. In this context, it 
is still necessary to conduct new studies with the objec-
tive of comparing its effects with Flutter® VRP1 or even 
with conventional respiratory physical therapy.
When Flutter® VRP1 and Acapella are compared 
in different PEPs and flows, the authors observe that, in 
the extremes (from 5 to 30 L), the Acapella generates 
little oscillation in airflows, in pressure amplitude and 
in frequency. Besides, when compared to Flutter®, the 
latter generates higher oscillation in amplitude, even in 
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low flows24. Diottix® was built to maintain the frequency 
fixed, however, our study showed that the amplitude ranges 
considerably when applied in the thorax, since this vari-
able depends on biological tissues that suffer the action 
from the equipment, thus justifying the wide variation. 
Besides, the comparison with previous studies becomes 
hard, since the variables in this study were obtained 
directly from the thorax, while, in others, variables were 
obtained directly from Flutter® VRP1 or from Acapella24.
Another group compared the Acapella, the Flutter® 
VPR1 and the Shaker. Frequencies were similar in all of 
the devices, and the amplitude of the wave was different 
between them10. The Acapella® Choice, Acappela® Blue, 
Acapella® Green were also compared with the water 
bottle. All of the tested devices reached 12 to 15 Hz7 in 
the airway frequency.
In this study, despite the amplitude variation, the fre-
quency remained constant, which is a great advantage 
for Diottix®, since the frequency of oral oscillators and 
bronchial hygiene maneuvers can range considerably.  
Study limitations
Even though this study has important information about 
the frequency and amplitude of the waves provoked by 
Diottix®, it is still necessary to conduct validation and 
reproducibility studies about this equipment. 
The frequency evaluation was made with cutaneous 
sensors, which can change the frequency of vibration 
due to the influence of other tissues, like skin. Therefore, 
studies assessing the pressure generated in the tho-
rax when Diottix® is performed need to be produced. 
The investigation was led in the thorax of healthy sub-
jects, in the absence of hypersecretion, so it was neces-
sary to understand the behavior of these variables in the 
hypersecretion patient However, in this analysis, it was 
important to investigate the behavior of the amplitude 
and frequency of the wave at the absence of pulmonary 
disease. In this context, further studies must be focused 
on the investigation about the use of the device to pro-
mote bronchial hygiene.
CONCLUSION
Diottix® produces frequencies in the thorax according 
to the device calibration, so it can be a complementary 
resource to bronchial hygiene maneuvers for respira-
tory physical therapists. However, the wave amplitudes 
seem to be affected by other structures, which include 
bone parts and the heart.
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